🇺🇸 FDA
Patent

US 11311551

Use of H3K9me3 modulation for enhancing cognitive function

granted A61KA61K31/202A61K31/27

Quick answer

US patent 11311551 (Use of H3K9me3 modulation for enhancing cognitive function) held by The Regents of the University of California expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/202, A61K31/27, A61K31/445, A61K31/473